More Medicare patients will have access to next-generation sequencing for inherited ovarian or breast cancer

Announcement by the Centers for Medicare & Medicaid Services (CMS), will now cover more Medicare patients access to next-generation sequencing (NGS) for patients with inherited ovarian or breast cancer.  The expansion of testing creates a new opportunity for patients with inherited cancers to get more personalized care where few treatment options are available.  Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.